Endocrinology and Metabolism Clinics of North America

Papers
(The TQCC of Endocrinology and Metabolism Clinics of North America is 5. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-07-01 to 2024-07-01.)
ArticleCitations
An Update on the Epidemiology of Type 2 Diabetes187
The Epidemiology of Pituitary Adenomas148
Postmenopausal Osteoporosis127
Physiology of Calcium Homeostasis55
Lipid and Lipoprotein Metabolism51
Pituitary Tumors Centers of Excellence43
Diabetes Insipidus42
Diagnosis of Polycystic Ovary Syndrome40
Prevention of Microvascular Complications of Diabetes36
Screening for Diabetes and Prediabetes32
Pediatric Thyroid Cancer30
Diabetes and Osteoporosis29
Assessment of Cardiovascular Disease Risk28
Aggressive Pituitary Adenomas and Carcinomas28
2022 Update on Clinical Management of Graves Disease and Thyroid Eye Disease28
New and Emerging Technologies in Type 1 Diabetes27
Update on the Genetics of Pituitary Tumors25
Anaplastic Thyroid Cancer25
Management of Hypothalamic Obesity23
Advances in the Imaging of Pituitary Tumors23
The Role of Dopamine Agonists in Pituitary Adenomas22
Advances in the Medical Treatment of Cushing Disease19
The Changing Nature of Mortality and Morbidity in Patients with Diabetes19
Characterizing Multimorbidity from Type 2 Diabetes18
Osteoporosis18
Endoscopic Surgery for Pituitary Tumors17
Inhaled Corticosteroids and Endocrine Effects in Childhood17
Cardiometabolic Risk in Polycystic Ovary Syndrome16
Acromegaly16
Definition and Classification of Diabetes and Prediabetes and Emerging Data on Phenotypes15
World Health Ozganization 2017 Classification of Pituitary Tumors15
Ethnic Disparities in Diabetes14
Dyslipidemia in Diabetes14
Testosterone Replacement Therapy in Hypogonadal Men14
Polycystic Ovary Syndrome14
Regulation of the Hypothalamic-Pituitary-Testicular Axis: Pathophysiology of Hypogonadism13
Hereditary Primary Hyperparathyroidism13
Nelson’s Syndrome13
Update on Rare Adverse Events from Osteoporosis Therapy and Bisphosphonate Drug Holidays13
Updates on Osteoporosis in Men13
Safety of Statins and Nonstatins for Treatment of Dyslipidemia13
Pediatric Type 2 Diabetes: Not a Mini Version of Adult Type 2 Diabetes13
A Novel Etiology of Hypophysitis12
Role of Bone Turnover Markers in Osteoporosis Therapy12
Nonclassic Congenital Adrenal Hyperplasia12
Diabetes and Osteoporosis12
Epidemiology of Male Hypogonadism11
Delayed and Precocious Puberty: Genetic Underpinnings and Treatments11
Hypertriglyceridemia11
Obesity and Aging11
Testosterone, Diabetes Risk, and Diabetes Prevention in Men11
Genetics of Polycystic Ovary Syndrome11
Postmenopausal Hyperandrogenism10
Bone Health in Childhood Chronic Disease10
Denosumab Discontinuation in Patients Treated for Low Bone Density and Osteoporosis10
Prevention of Type 2 Diabetes10
Testosterone Treatment As a Function-Promoting Therapy in Sarcopenia Associated with Aging and Chronic Disease9
Management of Women with Polycystic Ovary Syndrome During Pregnancy9
Phthalate Exposure, Adolescent Health, and the Need for Primary Prevention9
100 years of Insulin: Why is Insulin So Expensive and What Can be Done to Control Its Cost?9
Overview of Atypical Diabetes9
Nonalcoholic Fatty Liver Disease8
Management of Menopause Symptoms and Quality of Life during the Menopause Transition8
Evaluating the Impact of Acromegaly on Quality of Life8
Vitamin D–dependent Hypercalcemia8
Accurate Measurement and Harmonized Reference Ranges for Total and Free Testosterone Levels8
Pathophysiology of Hypercalcemia7
Hypercalcemia of Malignancy7
Diabetes in Youth7
Sexual Dysfunctions in Women6
Advances in the Bone Health Assessment of Children6
Symptoms of Late-Onset Hypogonadism in Men6
The Inherited Hypercholesterolemias6
Disparities in Thyroid Care6
The Future of Thyroid Nodule Risk Stratification6
Drug-Related Hypercalcemia6
Glucocorticoid- and Transplantation-Induced Osteoporosis6
Root Cause for Metabolic Syndrome and Type 2 Diabetes5
Quality of Life in Primary Hyperparathyroidism5
Treatment of Hypercalcemia of Malignancy5
Metabolic-Associated Fatty Liver Disease and Sarcopenia5
Rekindling Hope for Remission5
Parathyroid Carcinoma and Ectopic Secretion of Parathyroid hormone5
Male Reproduction and Aging5
Fertility Issues in Polycystic Ovarian Disease5
Diagnostic and Treatment Considerations for Thyroid Cancer in Women of Reproductive Age and the Perinatal Period5
Lipid Disorders and Metabolic-Associated Fatty Liver Disease5
Type 1 Diabetes and Aging5
Testicular Dysfunction Among Cancer Survivors5
Tertiary and Postrenal Transplantation Hyperparathyroidism5
Endocrine Sequelae in Childhood Cancer Survivors5
Hyperandrogenic Anovulation5
Pathobiology of Metabolic-Associated Fatty Liver Disease5
Update on Approved Osteoporosis Therapies Including Combination and Sequential Use of Agents5
0.030833005905151